Benefit of antiretroviral therapy on survival of human immunodeficiency virus-infected patients admitted to an intensive care unit
about
Sepsis is a major determinant of outcome in critically ill HIV/AIDS patientsClinical and immunologic predictors of death after an acute opportunistic infection: results from ACTG A5164.Mortality of patients infected with HIV in the intensive care unit (2005 through 2010): significant role of chronic hepatitis C and severe sepsis.Late HIV diagnosis is a major risk factor for intensive care unit admission in HIV-positive patients: a single centre observational cohort studyCritical illness in HIV-infected patients in the era of combination antiretroviral therapy.Early antiretroviral therapy for patients with acute aids-related opportunistic infections: a cost-effectiveness analysis of ACTG A5164Outcomes for critically ill patients with HIV and severe sepsis in the era of highly active antiretroviral therapy.Six-month survival of critically ill patients with HIV-related disease and tuberculosis: a retrospective study.Admissions to intensive care unit of HIV-infected patients in the era of highly active antiretroviral therapy: etiology and prognostic factors.Short- and long-term outcomes of HIV-infected patients admitted to the intensive care unit: impact of antiretroviral therapy and immunovirological status.Sepsis in AIDS patients: clinical, etiological and inflammatory characteristics.Spectrum of Opportunistic Infections and Risk Factors for In-Hospital Mortality of Admitted AIDS Patients in ShanghaiClinical review: Respiratory failure in HIV-infected patients--a changing picture.CLINICAL CHARACTERISTICS, OUTCOMES AND RISK FACTORS FOR DEATH AMONG CRITICALLY ILL PATIENTS WITH HIV-RELATED ACUTE KIDNEY INJURY.Critical care of persons infected with the human immunodeficiency virus.Ockham's razor is not so sharpThe changing epidemiology of HIV-infected patients in the intensive care unit.When to start ART in the setting of acute AIDS-related opportunistic infections: the time is now!All-cause mortality in hospitalized HIV-infected patients at an acute tertiary care hospital with a comprehensive outpatient HIV care program in New York City in the era of highly active antiretroviral therapy (HAART).Intensive Care Usage by HIV-Positive Patients in the HAART EraProvision of critical care services to HIV-infected children in an era of advanced intensive care and availability of combined antiretroviral therapy.Temporal trends in critical events complicating HIV infection: 1999-2010 multicentre cohort study in France.Association Between Depression and Antiretroviral Therapy Use Among People Living with HIV: A Meta-analysis.Epidemiology and Outcomes in Critically Ill Patients with Human Immunodeficiency Virus Infection in the Era of Combination Antiretroviral Therapy.A prospective study on the outcome of human immunodeficiency virus-infected patients requiring mechanical ventilation in a high-burden setting.Etiology and Outcome of Patients with HIV Infection and Respiratory Failure Admitted to the Intensive Care Unit.Should highly active antiretroviral therapy be prescribed in critically ill HIV-infected patients during the ICU stay? A retrospective cohort studyPredictors of the short- and long-term survival of HIV-infected patients admitted to a Brazilian intensive care unit.The ART of caring for patients with HIV infection in the ICUImproved Outcomes in Critically Ill Patients With AIDS: How Does This Trend Continue?Highly active antiretroviral therapy for critically ill HIV patients: A systematic review and meta-analysis.HIV-infected patients in the ICU in the current era of high-activity antiretroviral treatment.British HIV Association guidelines for the treatment of HIV-1-positive adults with antiretroviral therapy 2015Survival of HIV-infected patients admitted to the intensive care unit in the era of highly active antiretroviral therapy
P2860
Q34153349-9B395766-6B14-445D-B3E1-A6E7104EE90EQ34202331-F2C6C7D5-3AFC-43DC-875F-7F6C42182231Q34250648-0D8C361C-D992-49C2-8C10-191F22E02B02Q34554118-98D8636B-01CE-4530-8A86-CD91B2130840Q35095045-69E205B7-9D92-44E0-B985-7114D4EBE4B5Q35244295-2BA5B68A-244C-4E7D-9C62-AF62C0AFBFE8Q35718231-8AABEFCE-3C48-4A97-AC5C-4C3BA238F2D1Q36048584-A8639027-65B6-4E57-AA45-AFD3EE44B317Q36070543-5F3A866E-C558-4877-A5F2-C56BACADF18DQ36300347-6A4DC696-AC44-416C-AAD5-EA541BD5780EQ36588933-194FE484-96F5-449B-911E-642D6DBB040EQ36993017-3FCAB374-4E00-42E3-B092-F4065D0A5CE0Q36998358-D9F55FA4-8597-4AD6-90D3-A5D05CA14E06Q37134165-CFDADBAE-44EC-4007-9A49-20072DB3D2D8Q37205963-331A7776-97E0-4302-B99F-359BAFB2A8D8Q37481828-9FD25A6A-C65D-4689-A63C-325F6341E770Q37857545-FC48D05A-FCC7-49A7-A1BC-CBF50300DA97Q38021725-C687D87C-9090-46A3-A70B-08C2F9A386E7Q38069532-8C4227DF-784B-49F5-9792-9A73BE894832Q38897247-B53616A0-7F9A-4622-BF70-246D2C0FE39AQ39115804-F4EE0F29-327E-41E0-822D-13A3918B1B35Q39126703-AD9C4152-F6B3-4696-872F-BEE69DB98585Q39260412-41393A1C-1E14-4347-80DD-CD8C48FEC190Q40271126-0B5F3440-CF6D-447B-8CED-40A3D60A6782Q40934649-154D67D4-CD13-4B5B-981C-650D1CA522D7Q41893771-BE82A3D8-822F-419E-ACED-CF8B8AD823F7Q42030946-5B07FD4B-7302-412D-8BD5-0FCB9EDC6795Q42288655-407A9E66-E5E7-4864-AF97-46DC99A9D22DQ42562627-47DD1AD8-793A-4DFA-88B1-62FFFF24D993Q42854370-76998EA9-1DD1-480B-9AAB-0D7E8AC9DCAEQ47152806-3245BC3C-E275-43BF-A40C-3C7E5ADDD1ADQ55430766-5A94D2AE-9D4A-4EB2-A961-925570A58F8AQ57180790-55BED253-3357-43AE-8EF0-16CE090B5B1CQ57586341-12334CFC-0C5A-4EAA-9A6E-1241D47AF7F1
P2860
Benefit of antiretroviral therapy on survival of human immunodeficiency virus-infected patients admitted to an intensive care unit
description
2009 nî lūn-bûn
@nan
2009 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Benefit of antiretroviral ther ...... tted to an intensive care unit
@ast
Benefit of antiretroviral ther ...... tted to an intensive care unit
@en
Benefit of antiretroviral ther ...... tted to an intensive care unit
@nl
type
label
Benefit of antiretroviral ther ...... tted to an intensive care unit
@ast
Benefit of antiretroviral ther ...... tted to an intensive care unit
@en
Benefit of antiretroviral ther ...... tted to an intensive care unit
@nl
prefLabel
Benefit of antiretroviral ther ...... tted to an intensive care unit
@ast
Benefit of antiretroviral ther ...... tted to an intensive care unit
@en
Benefit of antiretroviral ther ...... tted to an intensive care unit
@nl
P2093
P2860
P921
P1476
Benefit of antiretroviral ther ...... tted to an intensive care unit
@en
P2093
Alan Neves
Julio Croda
Mariana Garcia Croda
Sigrid De Sousa dos Santos
P2860
P304
P356
10.1097/CCM.0B013E31819DA8C7
P407
P577
2009-05-01T00:00:00Z